Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2026-01-17 @ 11:22 PM
Study NCT ID:
NCT03533361
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2018-12-17
First Post:
2018-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil
Sponsor:
Organization: